2Y-Biopharma is a wholly-owned subsidiary of 2Y-Chem, it was established in 2017 as a high-quality CDMO platform, committed to serving the development of CMC and GMP production of new drug preparations in China and abroad; support the projects in various stages of clinical trial application (IND), clinical I/II/III, marketing application (NDA/ANDA) and commercial drug product manufacturing for MAH，which meets the requirements of Chinese, American and European regulations.

The platform has~13000 square meters of GMP facilities. There are 7 independent Class D workshops, which are designed and operated according to international cGMP standards, including oral solid preparations (including anti-tumor drugs production facility) and semisolid topical production lines for external use, equipped with fully functional QC laboratories, and the quality management system to ensure reliable product quality.

The strengths of the 2Y-Biopharma include Solubility-enhancing technology, controlled release technology, oral disintegration tablet and sublingual tablet technology as well as semi-solid emulsification and homogenization technology.

Formulation GMP facility - Qidong·Jiangsu
Formulation CMO: Tablets, hard capsules, granules, powders, cream, ointment and gel；
Including anti-tumor drugs (OEB3/4) production facility.
GMP facilities ~13000 square meters